Paclitaxel and cisplatin combined with concurrent involved-fie | Radiation Oncology | Articles preview

Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial
https://ro-journal.biomedcentral.com/articles/10.1186/s13014-022-02078-3

This trial aims to explore the efficacy and safety of involved-field irradiation (IFI) combined with paclitaxel plus cisplatin as concurrent chemoradiotherapy for locally advanced esophageal squamous cell carc...